LANGER DENNIS
SEC CIK 1274225 · EDGAR
BoughtSold
Most active insiders at QNRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LANGER DENNIS | Dir | $128.6K | — |
| 2 | Myers Michael | CEO, Dir | $100.0K | — |
| 3 | Carter Denise P. | COO, Dir | $100.0K | — |
| 4 | Lawlor Sally Bridget | CFO | $50.0K | — |
| 5 | Culverwell Anthony James | Dir | $30.0K | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-28 18:40 | 2026-08-27 | QNRX | Quoin Pharmaceuticals Ltd. | LANGER DENNIS | Dir | A - Grant | $5.15 | +34.5K | 56.2K | +159% | +$177.9K | |
| D | 2025-10-15 | 2025-10-14 | QNRX | Quoin Pharmaceuticals Ltd. | LANGER DENNIS | Dir | P - Purchase | $8.49 | +15.2K | 15.2K | +1,515,200% | +$128.6K |
| 2024-06-10 | 2024-06-07 | QNRX | Quoin Pharmaceuticals Ltd. | LANGER DENNIS | Dir | S - Sale | $0.73 | -297 | 53 | -85% | -$216.81 | |
| 2022-06-03 | 2022-06-02 | MYGN | MYRIAD GENETICS INC | LANGER DENNIS | Dir | A - Grant | $0.00 | +17.3K | 106.8K | +19% | $0 | |
| D | 2021-08-05 | 2021-08-03 | MYGN | MYRIAD GENETICS INC | LANGER DENNIS | Dir | S - Sale+OE | $34.75 | -30.0K | 89.5K | -25% | -$1.04M |
| D | 2021-08-05 | 2021-08-03 | MYGN | MYRIAD GENETICS INC | LANGER DENNIS | Dir | M - OptEx | $25.39 | +30.0K | 119.5K | +34% | +$761.7K |
Purchase Sale Sale after option exercise All abbreviations